Home
Live Updates
Is CRISPR safe? Genome editing gets its first FDA scrutiny : vimarsana.com
Is CRISPR safe? Genome editing gets its first FDA scrutiny
Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease. Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease.
Related Keywords
San Marcos ,
California ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Boston ,
Massachusetts ,
Tennessee ,
Memphis ,
Pennsylvania ,
Switzerland ,
San Francisco ,
Mark Walters ,
Meletios Verras Getty ,
Tosin Ola ,
Samira Kiani ,
Akshay Sharma ,
University Of Pittsburgh School Medicine ,
University Of California ,
Jude Children Research Hospital In Memphis ,
Shell ,
Vertex Pharmaceuticals ,
Drug Administration ,
Pittsburgh School ,
Jude Children ,
Research Hospital ,
Bluebird Bio ,
Sickle Cell Warriors ,
vimarsana.com © 2020. All Rights Reserved.